Trifluoroacetic acid → HCID 73058384, compound
Reaction equation
[C:1]([NH:5][C:6]([C:8]1[C:16]2[C:11](=[N:12][CH:13]=[C:14]([NH:17][C:18]3[S:22][N:21]=[C:20]([CH3:23])[CH:19]=3)[N:15]=2)[N:10](COCC[Si](C)(C)C)[CH:9]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2].FC(F)(F)C(O)=O>ClCCl.CO.[OH-].[NH4+]>[C:1]([NH:5][C:6]([C:8]1[C:16]2[C:11](=[N:12][CH:13]=[C:14]([NH:17][C:18]3[S:22][N:21]=[C:20]([CH3:23])[CH:19]=3)[N:15]=2)[NH:10][CH:9]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2]Participants
Procedure
To a solution of N-tert-butyl-2-(3-methylisothiazol-5-ylamino)-5-((2-(trimethylsilyl)ethoxy)methyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide (32 mg, 69.5 mol) in dichloromethane (1.2 mL) was added trifluoroacetic acid (158 mg, 107 μL, 1.39 mmol) and the mixture stirred at room temperature for 16 h. The reaction mixture was concentrated in vacuo and the residue obtained diluted with dichloromethane (1.2 mL), methanol (0.6 mL) and ammonium hydroxide (0.15 mL) and stirred at room temperature for 2 h. The mixture was concentrated and triturated with water. The solid was collected by filtration and washed with water and ether to give N-tert-butyl-2-(3-methylisothiazol-5-ylamino)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide (18 mg, 54.5 mol, 78.4%) as a brown solid. 1H NMR (400 MHz, DMSO-d) δ ppm: 12.55 (s, 1H), 11.39 (s, 1H), 8.15 (d, J=3.2, 1 H), 8.11 (s, 1H), 7.37 (s, 1H), 6.70 (s, 1H), 2.33 (s, 3H), 1.55 (s, 9H); MS (EI/CI) m/z: 331.1 [M+H].
Workup
- concentrationThe reaction mixture was concentrated in vacuo
- customthe residue obtained
- stirringstirred at room temperature for 2 h
- concentrationThe mixture was concentrated
- customtriturated with water
- filtrationThe solid was collected by filtration
- washwashed with water and ether
Sources & evidence
- ORD record
- ord-a9cb60912a6f4b8ab30696fd902cffa2
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09334278B2
Reaction notes
Loading…